JNJ

Which drugmakers have the healthiest presence on social media?
Which drugmakers have the healthiest presence on social media?
Medical Marketing and Media
social media
Eli Lilly
JNJ
Boehringer Ingelheim
Novo Nordisk
Flag link:
J&J Finally Returning to Its Roots in Diversity?
J&J Finally Returning to Its Roots in Diversity?
Yahoo/GuruFocus
JNJ
diversification
Flag link:
Johnson & Johnson Gets FDA Approval for Type 2 Diabetes Drug
Johnson & Johnson Gets FDA Approval for Type 2 Diabetes Drug
Market Realist
JNJ
FDA
type 2 diabetes
diabetes
Invokamet XR
Janssen
Flag link:
Novartis preps Zykadia for a frontline NSCLC pitch, but faces a tough rival in Roche; J&J, GSK hustle RA drug sirukumab to the FDA
Novartis preps Zykadia for a frontline NSCLC pitch, but faces a tough rival in Roche; J&J, GSK hustle RA drug sirukumab to the FDA
Endpoints
Novartis
Zykadia
non-small cell lung cancer
Roche
JNJ
GSK
rheumatoid arthritis
sirukumab
Flag link:
Who's Got The Best Pipeline: Pfizer, Merck Or Johnson & Johnson?
Who's Got The Best Pipeline: Pfizer, Merck Or Johnson & Johnson?
Seeking Alpha
Pfizer
Merck
JNJ
Flag link:
Johnson & Johnson - Finally Putting Money To Work, Sticking With The Conglomerate Model
Johnson & Johnson - Finally Putting Money To Work, Sticking With The Conglomerate Model
Seeking Alpha
JNJ
Abbott Labs
M&A
Abbott Medical Optics
Flag link:
Abbott to sell its eye care business to J&J for about $4.33 bln
Abbott to sell its eye care business to J&J for about $4.33 bln
Yahoo/Reuters
Abbott Labs
JNJ
M&A
eye health
Abbott Medical Optics
Flag link:
J&J to start testing vaccine for Ebola strains, Marburg virus
J&J to start testing vaccine for Ebola strains, Marburg virus
Stat
JNJ
vaccines
ebola virus
Marburg virus
Flag link:
J&J, GSK advance their PhIII IL-6 rheumatoid arthritis drug down to a busy red zone
J&J, GSK advance their PhIII IL-6 rheumatoid arthritis drug down to a busy red zone
Endpoints
JNJ
GSK
rheumatoid arthritis
sirukumab
FDA
Europe
Flag link:
Former J&J Sales Rep Convicted in Stolen Devices Scheme
Former J&J Sales Rep Convicted in Stolen Devices Scheme
Qmed
sales reps
devices
JNJ
Ethicon
Flag link:
Geron shares plunge as J&J assesses another setback for imetelstat
Geron shares plunge as J&J assesses another setback for imetelstat
Endpoints
Geron
JNJ
imetelstat
Flag link:
Gilead Sciences, Inc. a Takeover Target? It's Not as Crazy As It Sounds
Gilead Sciences, Inc. a Takeover Target? It's Not as Crazy As It Sounds
Motley Fool
Gilead Sciences
M&A
JNJ
Novartis
Amgen
Pfizer
Merck
Flag link:
Pfizer Takes Aim at Johnson & Johnson
Pfizer Takes Aim at Johnson & Johnson
Motley Fool
Pfizer
JNJ
Remicade
biosimilar
Inflectra
Flag link:
J&J advances through PhII with a promising hep C triple and 100% cure rate
J&J advances through PhII with a promising hep C triple and 100% cure rate
Endpoints
JNJ
hepatitis C
clinical trials
odalasvir
AL-335
Olysio
Achillion
Flag link:
J&J Wins Dismissal of Two New Jersey Talc Cancer Lawsuits
J&J Wins Dismissal of Two New Jersey Talc Cancer Lawsuits
Bloomberg
JNJ
Flag link:
Intuitive Surgical sues J&J’s Ethicon for ‘legal gymnastics’ over sales rep’s non-compete
Intuitive Surgical sues J&J’s Ethicon for ‘legal gymnastics’ over sales rep’s non-compete
Mass Device
Intuitive Surgical
JNJ
Ethicon
non-compete
sales rep
devices
Flag link:
Top 5 Drug Stocks of 2016
Top 5 Drug Stocks of 2016
Investopedia
AbbVie
JNJ
Celgene
Biogen
Bristol-Myers Squibb
Flag link:
Deutsche Takes A Look At Johnson & Johnson's Patent Woes
Deutsche Takes A Look At Johnson & Johnson's Patent Woes
Yahoo/Benzinga
JNJ
patents
Remicade
Pfizer
biosimilars
rheumatoid arthritis
Flag link:
J&J Remicade Patent Found Invalid in U.S. Victory for Pfizer
J&J Remicade Patent Found Invalid in U.S. Victory for Pfizer
Bloomberg
Pfizer
JNJ
Remicade
biosimilars
Inflectra
Celltrion
Hospira
Flag link:
Yet another state sues J&J for allegedly hiding vaginal mesh risks
Yet another state sues J&J for allegedly hiding vaginal mesh risks
Stat
JNJ
devices
Kentucky
vaginal mesh
Flag link: